Translate to...

Nemolizumab beats placebo for reduction of pruritus in eczema

Nemolizumab beats placebo for reduction of pruritus in eczema

(HealthDay)—For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of Medicine.